Regenerative plastic surgery
著者
書誌事項
Regenerative plastic surgery
（Plastic and reconstructive surgery series）
Nova Science Publishers, c2021
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Regenerating damaged organs and tissues, an act that once was considered magic, is currently entrusted to the surgeons who have allowed us to move from replacement and reconstructive plastic surgery to regenerative plastic surgery, through autologous and allogeneic cell-based therapies and growth factors. The enthusiasm for regenerative plastic surgery and for the treatment of some pathologies addressed by it, such as breast reconstruction, hemifacial atrophy, burns, scars, and aesthetic improvements such as breast and buttock augmentation, face rejuvenation and hair regrowth, has led the author, Professor Pietro Gentile, to rigorously investigate the possible new minimally invasive strategies based on adipose-derived stem cells, human follicle stem cells and growth factors contained in platelet-rich plasma. This book reports on the latest knowledge regarding the treatment of soft and bone tissue defects. Therefore, the goal of this text is to introduce and definitively establish this new and interesting field of plastic surgery, called regenerative plastic surgery.
目次
- Preface
- Acknowledgments
- Application of Platelet-Rich Plasma (PRP) in Regenerative Plastic Surgery
- Application of Fat Graft in Regenerative Plastic Surgery
- Autologous Platelet-Rich Plasma (A-PRP): Clinical Use of Activated or Not-Activated A-PRP in Androgenetic Alopecia (AGA)
- Clinical Use of Autologous Human Adipose Tissue-Derived Hair Follicle Stem Cells (HAD-HFSCS) in Androgenetic Alopecia
- Clinical Use of Autologous Fluid Cartilage as Biomaterial in the Treatment of Minor Nose Defects
- Gluteal Augmentation Using Autologous Fat Grafting
- Application of Fat Graft Enhanced with Platelet-Rich Plasma and/or Adipose-Derived Stem Cells in Outcomes of Scars
- Biomaterials, Growth Factors and Stem Cell Therapy in Wound Healing
- Stromal Vascular Fraction (SVF) and Adipose-Derived Mesenchymal Stem Cells (AD-MSCS) as a Potential, Safe and Effective Therapy in Combating Coronavirus Disease 2019 (COVID-19)
- FDA and European Rules Regarding Use of Adipose Derived-Stem Cells (ASCS), Human Follicle Mesenchymal Stem Cells (HF-MSCS) and Platelet-Rich Plasma (PRP) in Regenerative Plastic Surgery
- Index.
「Nielsen BookData」 より
